IGC Pharma’s (NYSE: IGC) CEO Appears on Bloomberg TV Discussing Alzheimer’s Fast-Acting IGC-AD1 Pharmaceutical Therapeutic – More Stocks InsideIGC Pharma, Inc. (
NYSE: IGC), a clinical-stage AI biotechnology company focused on Alzheimer’s disease, is gaining investor attention after CEO Ram Mukunda appeared on Bloomberg TV discussing the company’s lead drug candidate, IGC-AD1, a potential fast-acting therapy for agitation associated with Alzheimer’s dementia .
